Temporal relation of ATP-sensitive potassium-channel activation and contractility before cardioplegia

Annals of Thoracic Surgery

Volumn 65, Issue 4 SUPPL., 1998, Pages 1077-1082

  Hebbar, Latha ^b   Houck, Ward V ^b   Zellner, James L ^b   Dorman, B Hugh ^b   Spinale, Francis G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APRIKALIM; GLIBENCLAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REPERFUSION; HYPOTHERMIA; NONHUMAN; PRIORITY JOURNAL; SWINE; WARMING;

ADENOSINE TRIPHOSPHATE; ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIOPLEGIC SOLUTIONS; CARDIOTONIC AGENTS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GLYBURIDE; HEART ARREST, INDUCED; HYPOTHERMIA, INDUCED; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOPROTERENOL; ISOTONIC SOLUTIONS; MICROSCOPY, VIDEO; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; PICOLINES; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PYRANS; RANDOM ALLOCATION; REWARMING; SWINE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0031954385     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4975(98)00092-7     Document Type: Article

References (26)

1. ATP channels in ischemic preconditioning. Cardiovasc Res 1994;28:783-7.
2. Tan HL, Mazon P, Verberne HJ, et al. Ischemic preconditioning delays ischemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels. Cardiovasc Res 1993;27:644-51.
3. + channel openers and "natural' cardioprotection. Trends Pharmacol Sci 1992;13:269-72.
4. Robertson DW, Steinberg ML. Potassium channel modulators: scientific applications and therapeutic promise. J Med Chem 1990;33:269-72.
5. Menasché P, Mouas C, Grousset C. Is potassium channel opening an effective form of preconditioning before cardioplegia? Ann Thorac Surg 1996;61:1764-8.
6. Menasché P, Kevelaitis E, Mouas C, Grousset C, Piwnica A, Bloch G. Preconditioning with potassium channel openers. A new concept for enhancing cardioplegic protection. J Thorac Cardiovasc Surg 1995;110:1606-14.
7. Cavallo MJ, Dorman BH, Spinale FG, Roy RC. Myocyte contractile responsiveness following hypothermic hyperkalemic cardioplegic arrest: disparity between exogenous calcium and β-adrenergic stimulation. Anesthesiology 1995;82:926-39.
8. Handy JR, Spinale FG, Mukherjee R, Crawford FA. Hypothermic potassium cardioplegia impairs myocyte recovery of contractility and inotropy. J Thorac Cardiovasc Surg 1994; 107:1050-8.
9. Cohen NM, Wise RM, Damiano RJ Jr. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate sensitive potassium channel opener. A novel form of myocardial protection? J Thorac Cardiovasc Surg 1993;106:317-28.
10. Damiano RJ, Cohen NM. Hyperpolarized arrest attenuates myocardial stunning following global surgical ischemia: an alternate to traditional hyperkalemic cardioplegia? J Card Surg 1994;9:517-25.
11. + cardioplegia. Int J Cardiol 1995;48:11-25.
12. ATP openers in ischemic rat hearts treated with a potassium cardioplegic solution. J Cardiovasc Pharmacol 1995;26:698-706.
13. + channel? Circ Res 1995;77:1030-5.
14. Armstrong SC, Liu GS, Downey JM, Ganote CE. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J Mol Cell Cardiol 1995;27:1765-74.
15. Engelman DT, Chen CZ, Watanabe M, et al. Hypoxic preconditioning enhances functional recovery after prolonged cardioplegic arrest. Ann Thorac Surg 1995;59:428-32.
16. Illes RW, Wright JK, Inners-McBride K, Yang CJ, Tristan A. Ischemic preconditioning improves preservation with crystalloid cardioplegia. Ann Thorac Surg 1994;58:1481-5.
17. O SJ, Zellner JL, Cox MH, et al. Contributory mechanisms for the beneficial effects of myocyte preconditioning during cardioplegic arrest. Circulation 1996;94(Suppl 9):II389-97.
18. Lawton JS, Harrington GC, Allen CT, Hsia PW, Damiano RJ. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann Thorac Surg 1996;61:1680-8.
19. Lawton JS, Sepic JD, Allen CT, Hsia PW, Damiano RJ. Myocardial protection with potassium channel openers is as effective as St. Thomas' solution in the rabbit heart. Ann Thorac Surg 1996;62:31-8.
20. Damiano RJ Jr. The electrophysiology of ischemia and cardioplegia: implications for myocardial protection. J Card Surg 1995;10(Suppl 4):445-53.
21. 2+ waves: a laser confocal microscopy study. Am J Physiol 1996;270:H1384-9.
22. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-52.
23. Yao Z, Gross GJ. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Circulation 1994;89:1229-36.
24. 1B-adrenoreceptors, pertussis-sensitive G proteins, and protein kinase C. Circulation 1995;92:2259-65.
25. Sugden PH, Bogoyevitch MA. Intracellular signalling through protein kinases in the heart. Cardiovasc Res 1995;30:478-95.
26. Kirvatis RJ, Krukenkamp IB, Levitsky S. The cellular pathways involved in pharmacological preconditioning are mediated through a codependent interrelationship of the ATP-sensitive potassium channel and protein kinase C. Circulation 1996;94:I392.